ADC Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.2%.


Top Shareholders

Top 25 shareholders own 89.91% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.82%
Auven Therapeutics Management L.L.L.P
16,642,483$81.4m0%no data
9.61%
FMR LLC
7,681,046$37.6m0%no data
9.4%
Redmile Group, LLC
7,512,029$36.7m1.07%1.18%
9.32%
Hpwh Th Ag
7,450,000$36.4m0%no data
5.97%
ADC Products Switzerland SARL
4,773,122$23.3m0%no data
5.02%
AstraZeneca PLC
4,011,215$19.6m0%no data
4.23%
J.P. Morgan Asset Management, Inc.
3,379,418$16.5m0.92%no data
3.71%
AllianceBernstein L.P.
2,961,624$14.5m0.15%0.01%
2.45%
T. Rowe Price Group, Inc.
1,961,210$9.6m-20.36%no data
2.35%
Eventide Asset Management, LLC
1,879,959$9.2m-4.81%0.19%
2.17%
Christopher Martin
1,731,999$8.5m0%no data
1.97%
Hans-Peter Wild
1,573,688$7.7m0%no data
1.62%
Grosvenor Capital Management, L.P.
1,298,012$6.3m-14.45%1.13%
1.62%
Pictet Asset Management Limited
1,295,018$6.3m0%0.01%
1.57%
Michael Forer
1,258,556$6.2m0%no data
1.48%
Vantage Consulting Group, Inc.
1,186,215$5.8m-29.4%1.02%
1.24%
Ron Squarer
990,931$4.8m0%no data
1.11%
Walleye Capital LLC
888,700$4.3m257.84%0.07%
0.74%
Medical Strategy GmbH, Asset Management Arm
592,784$2.9m4.04%0.2%
0.65%
Thomas Pfisterer
521,544$2.6m0%no data
0.63%
Hillhouse Investment Management, Ltd.
500,000$2.4m0%0.01%
0.58%
BlackRock, Inc.
466,804$2.3m53.44%no data
0.57%
Thomas Rinderknecht
451,836$2.2m0%no data
0.57%
American Century Investment Management Inc
451,827$2.2m7.25%no data
0.51%
Principal Global Investors, LLC
406,102$2.0m33.04%no data